REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/05/2025
Back to search
Official data from USPTO
RESPIVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
05/06/2025
Trademark type
Word
Nice classes
5
Filing date
12/14/2017
Registration date
05/05/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2020
Last transaction
05/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/07/2020
First use in commerce
01/07/2020
Drawing code
4
Owner type
03
Owner location
Peachtree City, GA
Examiner
LEE, DOUGLAS
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HUVEPHARMA INC.
HUVEPHARMA INC.
AGRI-LABORATORIES, LTD.
Representatives
Charles G. Zug Nelson Mullins Riley & Scarborough LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Veterinary preparationsvaccinesoral and injectable antimicrobial preparations for the treatment of bovine respiratory diseaseinfectious bovine rhinotracheitis (IBR)bovine viral diarrhea (BVD 1 and BVD 2)bovine respiratory syncytial virus (BRSV)parainfluenza (PI3)pasteurella multocidamannheimia haemolytica; bacteriophage antimicrobials for the treatment of bovine respiratory diseaseinfectious bovine rhinotracheitis (IBR)bovine viral diarrhea (BVD 1 and BVD 2)bovine respiratory syncytial virus (BRSV)parainfluenza (PI3)pasteurella multocidamannheimia haemolytica; immunorestorative biopharmaceuticals for the treatment of bovine respiratory diseaseinfectious bovine rhinotracheitis (IBR)bovine viral diarrhea (BVD 1 and BVD 2)bovine respiratory syncytial virus (BRSV)parainfluenza (PI3)pasteurella multocidamannheimia haemolytica; parasiticides; insecticides; medicinal drugs for the treatment of bovine respiratory diseaseinfectious bovine rhinotracheitis (IBR)bovine viral diarrhea (BVD 1 and BVD 2)bovine respiratory syncytial virus (BRSV)parainfluenza (PI3)pasteurella multocidamannheimia haemolytica; dietary supplements; and hormone preparations
Publications
History of USPTO decisions and trademark events.
37 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/25/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/25/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/25/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/25/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/25/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/31/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/30/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/27/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/27/2020
IUAF
USE AMENDMENT FILED
03/10/2020
EISU
TEAS STATEMENT OF USE RECEIVED
03/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/16/2019
EX2G
SOU EXTENSION 2 GRANTED
08/14/2019
EXT2
SOU EXTENSION 2 FILED
08/14/2019
EEXT
SOU TEAS EXTENSION RECEIVED
08/14/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/12/2019
EX1G
SOU EXTENSION 1 GRANTED
03/08/2019
EXT1
SOU EXTENSION 1 FILED
03/08/2019
EEXT
SOU TEAS EXTENSION RECEIVED
03/08/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/31/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/11/2018
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/01/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/18/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/22/2018
PUBO
PUBLISHED FOR OPPOSITION
05/22/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/02/2018
ALIE
ASSIGNED TO LIE
04/16/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
04/02/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/02/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
04/02/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/02/2018
DOCK
ASSIGNED TO EXAMINER
03/26/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/29/2017
NWAP
NEW APPLICATION ENTERED
12/18/2017
Continuous trademark protection
Get notified about every new filing that threatens RESPIVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.